Clinical Development
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
Clinical Development
Sep 30, 2024, 08:39 |
Opinion
Tanja Obradovic: Strategy of clinical development in oncology requires global considerations
Tanja Obradovic shared the following on LinkedIn: “Strategy of clinical development in oncology always encompasses…
Sep 12, 2024, 19:27 |
Blog
Felix Lichtenegger: Highly effective Steering Committee Meeting with leading US lung cancer specialists
Felix Lichtenegger, Vice President Clinical Development at CatalYm GmbH, reposted a post by CatalYm GmbH on LinkedIn,…
Aug 26, 2024, 21:24 |
Blog
Tanja Obradovic: Can we expect new EGFR TKI to surpass osimertinib in primary tumor and intracranial progression of NSCLC
Tanja Obradovic posted on LinkedIn: “Can we expect new EGFR TKI that can significantly surpass…
Jul 8, 2024, 12:29 |
Drugs
Jennifer Buell: NCI Announces Availability of Botensilimab for Clinical Development
Jennifer Buell, President and Chief Executive Officer of MiNK Therapeutics, shared on X: “NCI Announces…
May 15, 2024, 10:13 |
Blog
Patient dosing has commenced in the Phase 1 clinical trial of SENTI-202 - Senti Biosciences
Tim Lu, Co-Founder and CEO at Senti Biosciences, shared the following post by Senti Biosciences…
May 10, 2024, 01:24 |
Career
Monique Tello is starting a new position as Medical Director of Clinical Development at Immunocore
Monique Tello, Medical Director, Clinical Development at Immunocore, shared on LinkedIn: "I’m happy to share that…
Apr 20, 2024, 08:16 |
Blog
Tanja Obradovic: One exciting novel approach is just about to enter clinical development
Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON plc, shared a post on LinkedIn: "Cell…
Apr 12, 2024, 17:18 |
Drugs
Tanja Obradovic: Interesting statistics on the nature of licensing deals in pharmaceutics during last year
Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON, recently shared on LinkedIn: “Interesting…
Feb 19, 2024, 18:18 |
Blog
Anas Younes: We are developing more than one drug for the same disease indication, so we can build future combination regimens
Anas Younes posted on LinkedIn: ''Our hematology team spent the last 3 days reviewing our…
All:
9
Posts:
1 - 100
Gavin Creel: Broadway Icon Dies After Battle with Rare Sarcoma at 48
Targeted Therapy vs Immunotherapy: Which Is Right for You, Key Differences & Similarities
ASTRO 24: 15 Posts Not to Miss From Day 2
Julia Louis-Dreyfus and Breast Cancer: How She Went Against, How She Survived, and More
ASTRO24: 20 Posts Not To Miss From Day 1
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube